COVID-19: Delaying 2nd Pfizer jab is an ‘unregulated and unlicensed’ trial

by

About This Source - Sky News

Sky News is a British free-to-air television news channel and organisation. Sky News is distributed via a radio news service, and through online channels. It is owned by Sky Group, a division of Comcast. John Ryley is the head of Sky News, a role he has held since June 2006.

Recent from Sky News:

  • US: Teen suicides rise as lockdown takes toll
  • Sky News Breakfast: Nightclubs could face ‘extinction’
  • BREAKING: Care home visits could resume within weeks – Minister

    • Sky News published this video item, entitled “COVID-19: Delaying 2nd Pfizer jab is an ‘unregulated and unlicensed’ trial” – below is their description.

    A GP in the Doctors’ Association explains why they are ‘concerned’ about delaying the second dose of the Pfizer vaccine.

    Patients have been told they’ll have to wait 12 weeks between the two jabs, longer than the manufacturer recommends.

    The decision was approved by the regulator, the Medicines and Healthcare products Regulatory Agency on the 30th December.

    Sky News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Using High-Tech Tracking Devices To Help Track Coronavirus Outbreaks | NBC News NOW
  • Keir Starmer unveils British Recovery Bond post-Covid plan
  • US lab at center of Covid-19 conspiracy pushed by China
  • EU presents new trade strategy | DW News
  • Bill Gates: J&J, Novavax vaccines retain ‘a lot of capability’ against variants

    • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • First 30 Sydney suburbs to receive Pfizer COVID-19 vaccines revealed | 7NEWS
  • White House advisor: Vaccines may be less effective against variants, but still above threshold
  • Pfizer: South African variant could significantly reduce vaccine protection
  • Biden: All American Adults to Have Access to Covid Vaccine by End of July
  • Biden Says He Invoked Production Law for More Vaccine Doses

    • In This Story: Vaccine

    A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

    9 Recent Items: Vaccine

  • Planet Normal: Olympic swimmer Sharron Davies on vaccine passports and the transgender sport debate
  • Nepal clears China’s Sinopharm vaccine, 500,000 doses to be donated
  • Expert on progress in global vaccine equity
  • Should the Vaccine Be Mandatory for Care Home Workers? | Good Morning Britain
  • EU COVID-19 response: Too little, too late? | Conflict Zone
  • Doctors in Turkey battle suspicions over Covid-19 vaccines in remote communities
  • South Africa launches vaccine roll-out with Johnson & Johnson jab
  • TV channels to show Covid vaccine myth-busting video @BBC News live – BBC
  • BREAKING: Care home visits could resume within weeks – Minister

    • Leave a Comment